Amesite Inc

Amesite Inc(AMST)股票分析

$0.515

-0.021 (-4.15%)收盤時

Loading chart…
最高
0.537
開盤
0.537
成交量加權均價
0.52
成交量
24.47K
市值
7.04M
最低
0.515
成交金額
12.79K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.

AI 分析 of Amesite Inc (AMST)

賣出

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

估值指標

Amesite Inc(AMST)目前預期本益比為 0.00,5 年平均預期本益比為 -2.94。

預期本益比

合理
5 年均值 P/E
-2.94
目前P/E
0.00
高估
5.76
低估
-11.63

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-3.91
目前EV/EBITDA
0.00
高估
17.01
低估
-24.83

預期股價營收比

合理
5 年均值 P/S
1.59
目前P/S
0.00
高估
4.22
低估
-1.04

事件時間軸

2026-09-24 (ET)

07:00:00

Amesite Launches New Sales Model, NurseMagic Enterprise Priced at $1,099 per Month

2026-05-12 (ET)

17:30:00

Amesite Files Prospectus for Resale of 4.84M Shares

2026-04-27 (ET)

12:40:00

Amesite Issues 696,866 Shares at $1.435 Each

11:20:00

X-energy and Yesway Show Strong Debut Performance

09:40:00

Amesite Files for Withdrawal of S-1 Registration Statement

資訊

AMST 常見問題 —— 由 Alphio AI 解答

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易